ALLMedicine™ Cholangitis Center
Research & Reviews 6,163 results
https://doi.org/10.1007/s12328-021-01397-4 10.1016/j.actatropica.2009.11.001 10.1186/s12879-018-3201-y 10.4269/ajtmh.18-0758 10.21037/jtd.2018.08.32 10.1093/trstmh/try050 10.1016/0016-5085(93)90355-G 10.1371/journal.pntd.0001154 10.1007/s00436-014-4275-0 10.4269/ajtmh.2011.10-0448 10.5114/aoms.2018.73344 10.1007/s003830200015 10.5455/medarh.2019.73.356-358 10.2214/AJR.16.16131 10.1007/s00464-005-0627-2 10.1080/00034983.1994.11812903 10.1046/j.1365-3156.1998.00257.x 10.1016/j.actatropica.2009.04.006 10.4269/ajtmh.18-0164 10.1371/journal.pntd.0001475 10.1016/j.parint.2005.11.037 10.1371/journal.pntd.0003883 10.1007/s10654-019-00492-8 10.4269/ajtmh.16-0187
Clinical Journal of Gastroenterology; Richter J, Lindner AK et. al.
Apr 14th, 2021 - Therapy choices for cystic echinococcisis (CE) are stage-specific: surgical, minimally invasive, medical or observation without intervention. PAIR (percutaneous aspiration, instillation of a scolicide, and re-aspiration) has been considered the tr...
https://doi.org/10.1097/MD.0000000000025526
Medicine Watanabe N, Ohno SI et. al.
Apr 13th, 2021 - In some cases, autopsy is the first opportunity to find a previously unrecognized critical infection. Pathogens are identified by various methods, such as microscopic examination, special stains, culture tests, and immunohistochemistry. Here, we r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953456
Transplantation Proceedings; Durazo FA, Nicholas AA et. al.
Apr 13th, 2021 - Liver injury is one of the nonpulmonary manifestations described in coronavirus disease 2019 (COVID-19). Post-COVID-19 cholangiopathy is a special entity of liver injury that has been suggested as a variant of secondary sclerosing cholangitis in c...
https://doi.org/10.1038/s41431-021-00854-5 10.1016/j.ajhg.2011.02.002 10.1038/s41581-018-0019-1 10.1016/j.ajhg.2010.11.011 10.1038/ng.3190 10.1038/ncomms10162 10.1093/bioinformatics/btm108 10.1038/ng.548 10.1038/ng.2310 10.1371/journal.pone.0046501 10.1038/s41598-018-23307-4 10.3389/fgene.2013.00232 10.1534/genetics.115.177220 10.1371/journal.pone.0175105 10.1038/ng.608 10.1038/jhg.2015.68 10.1038/ncomms9018 10.1038/s41598-018-36490-1 10.1086/519795 10.2307/2533274 10.1007/978-3-319-24277-4 10.1093/nar/gkv007 10.1375/twin.9.4.490 10.1007/978-4-431-54789-1 10.1038/s41598-017-11148-6 10.1016/j.ajhg.2012.08.010 10.1016/j.jcmgh.2018.11.006 10.1155/2014/727393 10.1007/s00535-012-0730-9 10.1038/s41598-018-26369-6 10.1101/gr.137323.112 10.1038/ng.3885 10.1016/j.jaut.2012.07.011 10.1016/j.jaut.2015.07.004 10.1016/j.jaut.2013.07.004 10.1371/journal.pone.0142683 10.1038/ng.2395 10.1056/NEJMoa0810440 10.1038/ng.627 10.1038/jhg.2015.59 10.1093/hmg/dds359 10.1371/journal.pgen.1004269 10.1038/s41598-018-26112-1
European Journal of Human Genetics : EJHG; Gervais O, Ueno K et. al.
Apr 9th, 2021 - While the advent of GWAS more than a decade ago has ushered in remarkable advances in our understanding of complex traits, the limitations of single-SNP analysis have also led to the development of several other approaches. Simulation studies have...
https://doi.org/10.1002/jhbp.966
Journal of Hepato-biliary-pancreatic Sciences; Yamada Y, Sasaki T et. al.
Apr 9th, 2021 - Stenting against recurrent biliary obstruction (RBO) after placement of covered metal stent (CMS) for distal malignant biliary obstruction (MBO) is still challenging. This study investigated the feasibility of a novel laser-cut fully-covered metal...
Guidelines 49 results
https://doi.org/10.1016/j.cgh.2019.07.011
Clinical Gastroenterology and Hepatology : the Official C... Bowlus CL, Lim JK et. al.
Jul 15th, 2019 - The purpose of this clinical practice update is to define key principles in the surveillance of hepatobiliary cancers including cholangiocarcinoma, gallbladder adenocarcinoma, and hepatocellular carcinoma in patients with primary sclerosing cholan...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691863
Gut Chapman MH, Thorburn D et. al.
Jun 3rd, 2019 - These guidelines on the management of primary sclerosing cholangitis (PSC) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included medical representatives from hepatology and gastroenter...
https://doi.org/10.1016/j.jacr.2019.02.020
Journal of the American College of Radiology : JACR; , Fairchild AH et. al.
May 5th, 2019 - Biliary obstruction is a serious condition that can occur in the setting of both benign and malignant pathologies. In the setting of acute cholangitis, biliary decompression can be lifesaving; for patients with cancer who are receiving chemotherap...
https://doi.org/10.1016/j.gie.2018.10.001
Gastrointestinal Endoscopy; , Buxbaum JL et. al.
Apr 13th, 2019 - Each year choledocholithiasis results in biliary obstruction, cholangitis, and pancreatitis in a significant number of patients. The primary treatment, ERCP, is minimally invasive but associated with adverse events in 6% to 15%. This American Soci...
https://doi.org/10.1002/jhbp.596
Journal of Hepato-biliary-pancreatic Sciences; Kamisawa T, Nakazawa T et. al.
Dec 23rd, 2018 - IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria o...
Drugs 2 results see all →
Clinicaltrials.gov 6,391 results
https://doi.org/10.1007/s12328-021-01397-4 10.1016/j.actatropica.2009.11.001 10.1186/s12879-018-3201-y 10.4269/ajtmh.18-0758 10.21037/jtd.2018.08.32 10.1093/trstmh/try050 10.1016/0016-5085(93)90355-G 10.1371/journal.pntd.0001154 10.1007/s00436-014-4275-0 10.4269/ajtmh.2011.10-0448 10.5114/aoms.2018.73344 10.1007/s003830200015 10.5455/medarh.2019.73.356-358 10.2214/AJR.16.16131 10.1007/s00464-005-0627-2 10.1080/00034983.1994.11812903 10.1046/j.1365-3156.1998.00257.x 10.1016/j.actatropica.2009.04.006 10.4269/ajtmh.18-0164 10.1371/journal.pntd.0001475 10.1016/j.parint.2005.11.037 10.1371/journal.pntd.0003883 10.1007/s10654-019-00492-8 10.4269/ajtmh.16-0187
Clinical Journal of Gastroenterology; Richter J, Lindner AK et. al.
Apr 14th, 2021 - Therapy choices for cystic echinococcisis (CE) are stage-specific: surgical, minimally invasive, medical or observation without intervention. PAIR (percutaneous aspiration, instillation of a scolicide, and re-aspiration) has been considered the tr...
https://doi.org/10.1097/MD.0000000000025526
Medicine Watanabe N, Ohno SI et. al.
Apr 13th, 2021 - In some cases, autopsy is the first opportunity to find a previously unrecognized critical infection. Pathogens are identified by various methods, such as microscopic examination, special stains, culture tests, and immunohistochemistry. Here, we r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953456
Transplantation Proceedings; Durazo FA, Nicholas AA et. al.
Apr 13th, 2021 - Liver injury is one of the nonpulmonary manifestations described in coronavirus disease 2019 (COVID-19). Post-COVID-19 cholangiopathy is a special entity of liver injury that has been suggested as a variant of secondary sclerosing cholangitis in c...
https://doi.org/10.1038/s41431-021-00854-5 10.1016/j.ajhg.2011.02.002 10.1038/s41581-018-0019-1 10.1016/j.ajhg.2010.11.011 10.1038/ng.3190 10.1038/ncomms10162 10.1093/bioinformatics/btm108 10.1038/ng.548 10.1038/ng.2310 10.1371/journal.pone.0046501 10.1038/s41598-018-23307-4 10.3389/fgene.2013.00232 10.1534/genetics.115.177220 10.1371/journal.pone.0175105 10.1038/ng.608 10.1038/jhg.2015.68 10.1038/ncomms9018 10.1038/s41598-018-36490-1 10.1086/519795 10.2307/2533274 10.1007/978-3-319-24277-4 10.1093/nar/gkv007 10.1375/twin.9.4.490 10.1007/978-4-431-54789-1 10.1038/s41598-017-11148-6 10.1016/j.ajhg.2012.08.010 10.1016/j.jcmgh.2018.11.006 10.1155/2014/727393 10.1007/s00535-012-0730-9 10.1038/s41598-018-26369-6 10.1101/gr.137323.112 10.1038/ng.3885 10.1016/j.jaut.2012.07.011 10.1016/j.jaut.2015.07.004 10.1016/j.jaut.2013.07.004 10.1371/journal.pone.0142683 10.1038/ng.2395 10.1056/NEJMoa0810440 10.1038/ng.627 10.1038/jhg.2015.59 10.1093/hmg/dds359 10.1371/journal.pgen.1004269 10.1038/s41598-018-26112-1
European Journal of Human Genetics : EJHG; Gervais O, Ueno K et. al.
Apr 9th, 2021 - While the advent of GWAS more than a decade ago has ushered in remarkable advances in our understanding of complex traits, the limitations of single-SNP analysis have also led to the development of several other approaches. Simulation studies have...
https://doi.org/10.1002/jhbp.966
Journal of Hepato-biliary-pancreatic Sciences; Yamada Y, Sasaki T et. al.
Apr 9th, 2021 - Stenting against recurrent biliary obstruction (RBO) after placement of covered metal stent (CMS) for distal malignant biliary obstruction (MBO) is still challenging. This study investigated the feasibility of a novel laser-cut fully-covered metal...
News 327 results
https://www.medscape.com/viewarticle/945131
Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...
https://www.medscape.com/viewarticle/943877
Jan 11th, 2021 - NEW YORK (Reuters Health) - The gut microbiomes of patients with primary sclerosing cholangitis (PSC) show major functional differences from those of healthy controls (HCs), new findings show. Individuals with PSC had fewer genes involved in synth...
https://www.staging.medscape.com/viewarticle/941007
Nov 13th, 2020 - Patients with primary biliary cholangitis experienced rapid improvements in itch and quality of life after treatment with linerixibat in a randomized placebo-controlled trial of the safety, efficacy, and tolerability of the small-molecule drug. Mo...
https://www.medscape.com/viewarticle/941007
Nov 13th, 2020 - Patients with primary biliary cholangitis experienced rapid improvements in itch and quality of life after treatment with linerixibat in a randomized placebo-controlled trial of the safety, efficacy, and tolerability of the small-molecule drug. Mo...
https://www.staging.medscape.com/viewarticle/940403
Nov 4th, 2020 - (Reuters Health) - Patients with moderate to severe primary or secondary sclerosing cholangitis experienced greater reduction of pruritis with bezafibrate than with placebo, a small trial found. Researchers examined data on 44 patients with primar...